loading

Pelthos Therapeutics Inc. Stock (PTHS) Forecast

The Pelthos Therapeutics Inc. (PTHS) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $15.58, representing a -23.07% decrease from the current price of $20.25. The highest analyst price target is $21.88, and the lowest is $9.2749.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month PTHS Price Target
Average 15.59 (-23.02% Downside)
loading

Is Pelthos Therapeutics Inc. (PTHS) A Buy Now?

Oscillators
Name Value Action
RSI(14) 39.89 Neutral
STOCH(9,6) 17.09 Buy
STOCHRSI(14) 61.49 Neutral
MACD(12,26) -0.9773 Buy
ADX(14) 16.52 Neutral
William %R -78.72 Neutral
CCI(14) -51.72 Neutral
Buy: 2 Sell: 0 Neutral: 5
Summary: Neutral
Moving Averages
Period Simple Exponential
MA10
20.50
Sell
20.58
Sell
MA20
21.38
Sell
21.26
Sell
MA50
23.88
Sell
23.03
Sell
MA100
25.47
Sell
24.31
Sell
MA200
24.82
Sell
25.22
Sell
Buy: 0 Sell: 10 Neutral: 0
Summary: Sell
According to our latest analysis, PTHS could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 10 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on PTHS, as trading bearish markets can be challenging and may result in losses.
  1. RSI (Relative Strength Index): The RSI(14) value of 39.89 indicates that PTHS is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 17.09 indicates that PTHS is oversold. This indicates that PTHS price is at or near the lowest level over a specified lookback period.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 61.49 indicates that PTHS is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of The ADX value of 16.52 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
  5. CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -51.72 indicates that PTHS is still oversold but not to an extreme extent.

Long-term PTHS price forecast for 2025, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Pelthos Therapeutics Inc. financial reports and earnings history, Pelthos Therapeutics Inc. (PTHS) stock could reach $0.7859 by 2030, $128.80 by 2040 and $219.88 by 2050. See the projected annual prices until 2050 of the Pelthos Therapeutics Inc. stock below:

  • Pelthos Therapeutics Inc. (PTHS) is expected to reach an average price of $38.18 in 2035, with a high prediction of $36.34 and a low estimate of $38.24. This indicates an $88.53% rise from the last recorded price of $20.25.
  • Pelthos Therapeutics Inc. (PTHS) stock is projected to chart a bullish course in 2040, with an average price target of $128.80, representing an $536.05% surge from its current level. The forecast ranges from a conservative $70.69 to a sky-high $128.80.
  • Our analysts predict Pelthos Therapeutics Inc. (PTHS) to jump 783.87% by 2045, soaring from $176.47 to an average price of $178.98, potentially reaching $175.23. While $176.47 is the low estimate, the potential upside is significant.
  • Pelthos Therapeutics Inc. (PTHS) stock is expected to climb by 2050, reaching an average of $216.90, a $971.11% jump from its current level. However, a wide range of estimates exists, with high and low targets of $219.88 and $216.16, respectively, highlighting the market's uncertainty.

Pelthos Therapeutics Inc. Stock (PTHS) Year by Year Forecast

Pelthos Therapeutics Inc. Stock (PTHS) Price Forecast for 2026

The predicted value for Pelthos Therapeutics Inc. (PTHS) in 2026 is set at an average of $20.13. Estimates vary from a peak of $30.99 to a trough of $9.2749, indicating an -0.58% surge from the present price of $20.25.
Month Average Low High Change from today's price
November, 2026 $19.97 $9.2749 $21.88 -1.40%
December, 2026 $15.71 $12.62 $24.55 -22.41%

Pelthos Therapeutics Inc. Stock (PTHS) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Pelthos Therapeutics Inc. (PTHS) is $13.64, with a high forecast of $20.65 and a low forecast of $6.6231. This indicates an -32.67% decrease from the last price of $20.25.
Month Average Low High Change from today's price
January, 2027 $13.37 $8.5359 $18.08 -33.99%
February, 2027 $11.06 $11.06 $19.36 -45.37%
March, 2027 $11.67 $6.6231 $15.17 -42.35%
April, 2027 $9.518 $8.753 $17.94 -53.00%
May, 2027 $12.22 $9.2229 $15.59 -39.63%
June, 2027 $15.05 $12.03 $15.86 -25.68%
July, 2027 $15.45 $14.20 $19.28 -23.71%
August, 2027 $16.10 $15.73 $20.00 -20.49%
September, 2027 $19.33 $13.93 $19.76 -4.52%
October, 2027 $15.75 $15.02 $20.65 -22.22%
November, 2027 $13.64 $9.5697 $17.29 -32.64%
December, 2027 $12.05 $11.32 $14.66 -40.51%

Pelthos Therapeutics Inc. Stock (PTHS) Price Forecast for 2028

In 2028, Pelthos Therapeutics Inc. (PTHS) is projected to reach an average price of $5.8591, with a high projection of $11.68 and a low estimate of $0.0387. This indicates an -71.07% fall from the last price of $20.25.
Month Average Low High Change from today's price
January, 2028 $2.5898 $0.2076 $7.0724 -87.21%
February, 2028 $7.8896 $1.9822 $11.68 -61.04%
March, 2028 $2.0407 $0.0945 $9.132 -89.92%
April, 2028 $5.1091 $0.7308 $7.1067 -74.77%
May, 2028 $0.4886 $0.0589 $5.5566 -97.59%
June, 2028 $0.3311 $0.0387 $4.0386 -98.36%
July, 2028 $1.5266 $0.4336 $6.6336 -92.46%
August, 2028 $3.7631 $0.6818 $4.9631 -81.42%
September, 2028 $6.1129 $3.738 $8.917 -69.81%
October, 2028 $9.3451 $5.0466 $9.9251 -53.85%
November, 2028 $7.9949 $4.3425 $10.25 -60.52%
December, 2028 $9.1947 $6.5074 $11.49 -54.59%

Pelthos Therapeutics Inc. Stock (PTHS) Price Forecast for 2029

The 2029 price forecast for Pelthos Therapeutics Inc. Stock (PTHS) is $6.2792 on average, with a high prediction of $11.62 and a low estimate of $0.9344. This represents an -68.99% decrease from the previous price of $20.25.
Month Average Low High Change from today's price
January, 2029 $4.4569 $3.7669 $10.34 -77.99%
February, 2029 $3.8467 $0.9344 $7.2018 -81.00%
March, 2029 $12.39 $3.1116 $6.85 -38.81%
April, 2029 $6.098 $9.068 $11.62 -69.89%
May, 2029 $9.6633 $8.1643 $8.2183 -52.28%
June, 2029 $11.32 $13.07 $10.87 -44.11%
July, 2029 $10.99 $9.2613 $10.87 -45.75%
August, 2029 $11.46 $11.77 $11.61 -43.40%
September, 2029 $12.93 $10.87 $8.666 -36.17%
October, 2029 $9.3576 $11.47 $10.80 -53.79%
November, 2029 $5.843 $6.6366 $8.814 -71.15%
December, 2029 $2.5446 $4.2946 $3.3506 -87.43%

Pelthos Therapeutics Inc. Stock (PTHS) Price Forecast for 2030

Pelthos Therapeutics Inc. Stock (PTHS) is expected to reach an average price of $13.21 in 2030, with a high forecast of $24.92 and a low forecast of $1.4966. This signifies an -34.79% decrease from the last price of $20.25.
Month Average Low High Change from today's price
January, 2030 $3.2399 $1.6373 $0.7859 -84.00%
February, 2030 $0.6847 $2.2503 $1.1147 -96.62%
March, 2030 $2.2106 $1.4966 $2.3421 -89.08%
April, 2030 $3.4573 $3.1633 $2.7659 -82.93%
May, 2030 $4.3626 $4.3713 $3.8999 -78.46%
June, 2030 $29.91 $23.14 $24.92 +47.68%
July, 2030 $17.83 $21.11 $23.38 -11.95%
August, 2030 $27.07 $25.28 $21.57 +33.69%
September, 2030 $22.41 $21.43 $23.30 +10.68%
October, 2030 $23.97 $23.59 $22.78 +18.36%
November, 2030 $22.46 $22.92 $23.26 +10.90%
December, 2030 $23.45 $22.18 $21.85 +15.82%
$7.525
price up icon 1.69%
$10.30
price up icon 0.68%
$18.89
price up icon 4.94%
$5.77
price up icon 5.58%
$10.94
price up icon 6.32%
WVE WVE
$3.205
price up icon 3.72%
Cap:     |  Volume (24h):